Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice

Peptides

Volumn 30, Issue 7, 2009, Pages 1348-1354

  Tian, Xiao zhu ^a   Chen, Juan ^a   Xiong, Wei ^a   He, Tian ^a   Chen, Qiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Aminopeptidase N; Antinociception; Enkephalins; Human opiorphin; Neutral endopeptidase; Opioid receptor

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; METENKEPHALIN; MORPHINE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIORPHIN; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; COLON MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; WATER IMMERSION;

ANALGESICS; ANIMALS; COLON; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MICE; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, OPIOID; SALIVARY PROTEINS AND PEPTIDES;

MUS;

EID: 67349175992     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.04.002     Document Type: Article

References (36)

1. al-Rodhan N., Chipkin R., and Yaksh T.L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res 520 (1990) 123-130
2. Aoki K., Kajiwara M., and Oka T. The in activation of [Met5]-enkephalin by bestatin sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Jpn J Pharmacol 40 (1986) 297-302
3. Aoki K., Kajiwara M., and Oka T. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum. Jpn J Pharmacol 36 (1984) 59-65
4. Boura A.L.A., and Olley J.E. Characterization of the excitatory opiate receptors in the rat large intestine. Br J Pharmacol 74 (1981) 246-247
5. Bourgoin S., Lebars D., Artaud F., Clot A.M., Bouboutou R., Fournie-Zaluski M.C., et al. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord. J Pharmacol Exp Ther 238 (1986) 360-366
6. Chou J., Tang J., DelRio J., Yang H.Y., and Costa E. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception. J Pharmacol Exp Ther 230 (1984) 349-352
7. Dickinson D.P., and Thiesse M. CDNA cloning of an abundant human lacrimal gland mRNA encoding a novel tear protein. Curr Eye Res 15 (1996) 377-386
8. Erdös E.G., and Skidgel R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3 (1989) 145-151
9. Fang Q., Guo J., Chang M., Chen L.X., Chen Q., and Wang R. Neuropeptide FF receptors exert contractile activity viainhibition of nitric oxide release in the mouse distal colon. Peptides 26 (2005) 791-797
10. Fontaine J., and Reuse J. Contractor responses of the isolated colon of the mouse to morphine and some opioid peptides. Br J Pharmacol 85 (1985) 861-867
11. Fu C.Y., Kong Z.Q., Wang K.R., Yang Q., Zhai K., Chen Q., et al. Effects and mechanisms of supraspinal administration of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Res 1056 (2005) 51-58
12. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
13. Hughes J., Kosterlitz H.W., and Smith T.W. The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissue. Br J Pharmacol 61 (1977) 639-647
14. 2 receptors. Br J Pharmacol 131 7 (2000) 1461-1467
15. Lecomte J.M., Costentin J., Vlaiculescu A., Chailiet P., Marcais-Collade H., Llorens-Cortes C., et al. Pharmacological properties of acetorphan, a parenterally active 'enkephalinase' inhibitor. J Pharmacol Exp Ther 273 (1982) 937-944
16. Le Guen S., Mas Nieto M., Canestrelli C., Chen H., Fournie-Zaluski M.C., Cupo A., et al. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone. Pain 104 (2003) 139-148
17. Liberge M., Rivètre P.J.M., and Buéno L. Influence of enkephalinase inhibitors on gastric emptying in mice depends on the nature of the meal. Life Sci 42 (1988) 2047-2053
18. Lord J.A.H., Waterfield A.A., Hughes J., and Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature 267 (1977) 495-499
19. Marcais-Collado H., Uchida G., Costentin J., Schwartz J.C., and Lecomte J.M. Naloxone reversible antidiarrhoeal effects of enkephalinase inhibitors. Eur J Pharmacol 144 2 (1987) 125-132
20. Nishimura K., and Hazato T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem Biophys Res Commun 194 (1993) 713-719
21. Noble F., Smadja C., Valverde O., Maldonado R., Corie P., Turcaud S., et al. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120. Pain 73 (1997) 383-391
22. Pierre J.M.R., Martine L., Divina M.L., and Lionel B. Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats. Br J Pharmacol 98 (1989) 236-242
23. Primi MP. Contrôle central neuropeptidergique et hormonal des sécrétions intestinales chez le chien. Thèse de Doctorat, Institut National Polytechnique de Toulouse. France; 1986.
24. Roques B.P., Fournie-Zaluski M.C., Soroca E., Lecomte J.M., Malfroy B., Llorens C., et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288 (1980) 286-288
25. Roques B.P., Noble F., Daug V., Fourni-Zaluski M.C., and Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45 (1993) 87-146
26. Roques B.P. Novel approaches to targeting neuropeptide systems. Trends Pharmacol Sci 21 (2000) 475-483
27. Rougeot C., Messaoudi M., Hermitte V., Rigault A.G., Blisnick T., Dugave C., et al. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proc Natl Acad Sci USA 100 (2003) 8549-8554
28. Rougeot C., Rosinski-Chupin I., and Rougeon F. Novel genes and hormones in salivary glands: from the gene for the submandibular rat1 protein (SMR1) precursor to receptor sites for SMR1 mature peptides. Biomed Rev 9 (1998) 17-32
29. Ruiz-Gayo M., Baamonde A., Turcaud S., Fournie-Zaluski M.C., and Roques B.P. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding. Brain Res 571 (1992) 306-312
30. Song B.B., and Marvizón J.C.G. Peptidases prevent μ-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. J Neurosci 23 5 (2003) 1847-1858
31. Sternini C., Patierno S., Selmer I.S., and Kirchgessner A. The opioid system in the GI tract. Neurogastroenterol Motil 16 (2004) 3-16
32. Waksman G., Hamel E., Fournié-Zaluski M.C., and Roques B.P. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of μ and δ opioid receptors in rats brain. Proc Natl Acad Sci USA 83 (1986) 1523-1527
33. Weber M.A. Vasopeptidase inhibitors. Lancet 358 (2001) 1525-1532
34. Wisner A., Dufour E., Messaoudi M., Nejdi A., Marcel A., Ungeheuer M.N., et al. Human opiorphin, an atural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci USA 103 (2006) 17979-17984
35. Yamamoto Y., Ono H., Ueda A., Shimamura M., Nishimura K., and Hazato T. Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation. Curr Protein Pept Sci 3 (2002) 587-599
36. Yu Y., Cui Y., Wang X., Lai L.H., Wang C.L., Fan Y.Z., et al. In vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for mu-opioid receptors, on mouse colonic motility. Biochem Pharmacol 73 (2007) 1384-1393